The Accuracy and Efficacy of the Dexcom G4 Platinum Continuous Glucose Monitoring System

    loading  Checking for direct PDF access through Ovid

Abstract

Background:

The purpose of this study was to evaluate the accuracy and efficacy of Dexcom G4 Platinum CGM System.

Methods:

Seventy-two subjects enrolled at 4 US centers; 61% were male; 83% had T1DM and17% had T2DM. Subjects wore at least 1 system for up to 7 days. Subjects participated in a total of 36 hours in the clinic to contribute YSI reference glucose measurements with venous blood draws every 15 minutes on study Day 1, Day 4, and Day 7.

Results:

The overall mean absolute relative difference (ARD) versus YSI was 13% with a median of 10%. Precision ARD was 9% ± 4% between 2 sensors with a 7% coefficient of variation. The mean ARD versus SMBG was 14% with a median of 11%. One hundred two (94%) sensors lasted 7 days and the systems displayed 97% of their expected glucose readings in average. The time spent in low CGM readings during nighttime hours decreased from the first night use to the 6th night (P < .001) with a small difference in average CGM glucose from 147 ± 40 mg/dL to 166 ± 62 mg/dL. There were no serious adverse events or infectious complications reported.

Conclusions:

The study showed the Dexcom G4 Platinum CGM System is one of the most accurate CGMs. The significant reduction in nocturnal time spent in a hypoglycemic state observed during this study suggests that a longer term study of CGM use, especially nocturnal use, could be beneficial for patients with hypoglycemia unawareness.

Related Topics

    loading  Loading Related Articles